Methylprednisolone microsphere sustained-release membrane inhibits scar formation at the site of peripheral nerve lesion.

Corticosteroids are widely used for the treatment of acute central nervous system injury. However, their bioactivity is limited by their short half-life. Sustained release of glucocorticoids can prolong their efficacy and inhibit scar formation at the site of nerve injury.